Natural killer T cells are targets for human immunodeficiency virus infection

Immunology

Volumn 108, Issue 1, 2003, Pages 1-2

  Crowe, Nadine Y ^a   Godfrey, Dale I ^a   Baxter, Alan G ^b  

^a MONASH UNIVERSITY   (Australia)

^b CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 4;

CELL FUNCTION; CLINICAL FEATURE; DEPLETION; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOCYTE COUNT; NATURAL KILLER CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; RETROVIRUS; T LYMPHOCYTE; TARGET CELL; VIRUS TRANSMISSION;

HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, HIV; T-LYMPHOCYTE SUBSETS;

EID: 0037244808     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01580.x     Document Type: Note

References (12)

1. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21:573.
2. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nature Rev Immunol 2002; 2:557.
3. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI. NKT cells - conductors of tumor immunity? Current Opin Immunol 2002; 14:165.
4. Fleuridor R, Wilson B, Runhua H, Landay A, Kessler H, Al-Harthi L. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology 2003; 108: 3-10.
5. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D. CD1d-restricted human natural killer T Cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002; 195:869.
6. +Va24 Natural killer T cells in human immunodeficiency virus infection. J Virol 2002; 76:7528.
7. + NKT cells during HIV type 1 infection. J Immunol 2002; 168:1490.
8. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nature Immunol 2001; 2:971.
9. Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1 (-) CD4 (+) CD1d-dependent precursor stage. J Exp Med 2002; 195:835.
10. Crowe NY, Smyth MJ, Godfrey DI. A critical role for natural killer T cells in immunosurveillance of methycholanthrene-induced sarcomas. J Exp Med 2002; 196:119.
11. Smyth MJ, Thia KY, Street SE et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000; 191:661.
12. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81:213-27.